Duey Marc
SEC insider (Form 3/4/5 filer). CIK 0001925150. Director at Aprea Therapeutics, Inc. (APRE). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in DOYLESTOWN, PA.
Companies Duey Marc has filed insider reports for
- Aprea Therapeutics, Inc. (APRE): Director
Duey Marc
CIK: 0001925150
Transaction Breakdown
Open Market Buys (P)3 (50.0%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APRE
Aprea Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect3.1K shares- - Dec 10, 2025APRE
Aprea Therapeutics, Inc.
PurchaseDirect21.5K shares at avg. $1.17$25K - Jun 5, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect1K shares- - Oct 18, 2024APRE
Aprea Therapeutics, Inc.
SaleDirect6.5K shares at avg. $4.58$30K - Oct 16, 2024APRE
Aprea Therapeutics, Inc.
PurchaseDirect30K shares at avg. $4.39$132K - Oct 14, 2024APRE
Aprea Therapeutics, Inc.
PurchaseDirect190 shares at avg. $2.58$490.2
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 | APRE Aprea Therapeutics, Inc. | Award | 3,135 | - | $0 | Direct |
| Dec 10, 2025 | APRE Aprea Therapeutics, Inc. | Purchase | 21,459 | $1.17 | $25,000 | Direct |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | Award | 1,045 | - | - | Direct |
| Oct 18, 2024 | APRE Aprea Therapeutics, Inc. | Sale | 6,462 | $4.58 | $29,583 | Direct |
| Oct 16, 2024 | APRE Aprea Therapeutics, Inc. | Purchase | 30,000 | $4.39 | $131,700 | Direct |
| Oct 14, 2024 | APRE Aprea Therapeutics, Inc. | Purchase | 190 | $2.58 | $490 | Direct |
1-6 of 6 transactions